Publicacións nas que colabora con Javier Rueda Gotor (16)

2024

  1. Sex-specific impact of inflammation on traditional cardiovascular risk factors and atherosclerosis in axial spondyloarthritis. A multicentre study of 913 patients

    RMD open, Vol. 10, Núm. 2

2021

  1. Potential relation of cardiovascular risk factors to disease activity in patients with axial spondyloarthritis

    Therapeutic Advances in Musculoskeletal Disease, Vol. 13

  2. Subclinical atherosclerotic disease in ankylosing spondylitis and non-radiographic axial spondyloarthritis. A multicenter study on 806 patients

    Seminars in Arthritis and Rheumatism, Vol. 51, Núm. 2, pp. 395-403

2020

  1. Disease Activity Influences Cardiovascular Risk Reclassification Based on Carotid Ultrasound in Patients with Psoriatic Arthritis

    Journal of Rheumatology, Vol. 47, Núm. 9, pp. 1344-1353

2018

  1. Relative Risk Chart Score for the Assessment of the Cardiovascular Risk in Young Patients with Ankylosing Spondylitis

    International Journal of Rheumatology, Vol. 2018

2014

  1. Antitumour necrosis factor α treatment reduces retinol-binding protein 4 serum levels in non-diabetic ankylosing spondylitis patients

    Annals of the Rheumatic Diseases

  2. Correlation between two biomarkers of atherosclerosis, osteopontin and angiopoietin-2, in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy

    Clinical and Experimental Rheumatology, Vol. 32, Núm. 2, pp. 231-236

  3. Gelsolin levels are decreased in ankylosing spondylitis patients undergoing anti-TNF-alpha therapy

    Clinical and Experimental Rheumatology, Vol. 32, Núm. 2, pp. 218-224

  4. IGF-1 and ADMA Levels Are Inversely Correlated in Nondiabetic Ankylosing Spondylitis Patients Undergoing Anti-TNF-Alpha Therapy

    BioMed Research International, Vol. 2014

  5. Osteoprotegerin correlates with disease activity and endothelial activation in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy

    Clinical and Experimental Rheumatology, Vol. 32, Núm. 5, pp. 640-646

  6. Patients with ankylosing spondylitis and low disease activity because of anti-TNF-Alpha therapy have higher TRAIL levels than controls: A potential compensatory effect

    Mediators of Inflammation, Vol. 2014

  7. Tocilizumab in refractory aortitis: A study on 16 patients and literature review

    Clinical and Experimental Rheumatology, Vol. 32, Núm. SUPPL.82

2013

  1. No evidence of association between functional polymorphisms located within IL6R and IL6ST genes and Henoch-Schönlein purpura

    Tissue Antigens, Vol. 82, Núm. 6, pp. 416-419

  2. SMAD3 rs17228212 Gene Polymorphism Is Associated with Reduced Risk to Cerebrovascular Accidents and Subclinical Atherosclerosis in Anti-CCP Negative Spanish Rheumatoid Arthritis Patients

    PLoS ONE, Vol. 8, Núm. 10

  3. The 11q23.3 genomic region-rs964184-is associated with cardiovascular disease in patients with rheumatoid arthritis

    Tissue Antigens, Vol. 82, Núm. 5, pp. 344-347

  4. The ZC3HC1 rs11556924 polymorphism is associated with increased carotid intima-media thickness in patients with rheumatoid arthritis

    Arthritis Research and Therapy, Vol. 15, Núm. 5